Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · see citing works

International System for Human Cytogenetic Nomenclature

National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,873 · see citing works

Human induced pluripotent stem cells free of vector and transgene sequences

Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386 · see citing works

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890 · see citing works

Chromosome instability is common in human cleavage-stage embryos

Vanneste, E., Voet, T., Le Caignec, C., Ampe, M., Konings, P., Melotte, C., Debrock, S., Amyere, M., Vikkula, M., Schuit, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.1924 · Cited by 880 · see citing works

Identification and classification of chromosomal aberrations in human induced pluripotent stem cells

Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.017 · Cited by 756 · see citing works

Adaptation to culture of human embryonic stem cells and oncogenesis in vivo

Baker, D., Harrison, N. J., Maltby, E. L., Smith, K., Moore, H. D. M., Shaw, P. J., Heath, P. R., Holden, H. M., & Andrews, P. W. (2007) · Nature Biotechnology · doi:10.1038/nbt1285 · Cited by 635 · see citing works

Genomic alterations in cultured human embryonic stem cells

Maitra, A., Arking, D. E., Shivapurkar, N., Ikeda, M. A., Stastny, V., Kassauei, K., Sui, G., Cutler, D. J., Liu, Y., Constable, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1631 · Cited by 617 · see citing works

Long‐term culture of human embryonic stem cells in feeder‐free conditions

Rosler, E. S., Fisk, G. J., Ares, X., Irving, J., Miura, T., Rao, M. S., & Carpenter, M. K. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10430 · Cited by 357 · see citing works

Defining ‘chromosomal instability’

Geigl, J. B., Obenauf, A. C., Schwarzbraun, T., & Speicher, M. R. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.006 · Cited by 344 · see citing works

High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity

Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz‐Eldor, J., Rasool, O., Dvořák, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 274 · see citing works

Aneuploidy: Instigator and Inhibitor of Tumorigenesis

Weaver, B. A. A., & Cleveland, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2266 · Cited by 195 · see citing works

Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells

Upender, M. B., Habermann, J. K., McShane, L. M., Korn, E. L., Barrett, J. C., Difilippantonio, M. J., & Ried, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0474 · Cited by 188 · see citing works

Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes

Initiative, T. I. S. C. B. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9085-x · Cited by 162 · see citing works

Tetrasomy 12p (Pallister-Killian syndrome).

Schinzel, A. (1991) · Journal of Medical Genetics · doi:10.1136/jmg.28.2.122 · Cited by 157 · see citing works

Developing safe therapies from human pluripotent stem cells

Carpenter, M., Frey-Vasconcells, J., & Rao, M. S. (2009) · Nature Biotechnology · doi:10.1038/nbt0709-606 · Cited by 147 · see citing works

High Resolution Array-CGH Characterization of Human Stem Cells Using a Stem Cell Focused Microarray

Elliott, A. M., Elliott, K. A. H., & Kammesheidt, A. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9294-1 · Cited by 59 · see citing works

Common genetic variation drives molecular heterogeneity in human iPSCs

Kilpinen, H., Goncalves, A., Leha, A., Afzal, V., Alasoo, K., Ashford, S., Bala, S., Bensaddek, D., Casale, F. P., Culley, O. J., et al. (2017) · Nature · doi:10.1038/nature22403 · Cited by 586 · see citing works

Modeling Alzheimer’s disease with iPSC-derived brain cells

Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471 · see citing works

Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application

Liang, G., & Zhang, Y. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.07.001 · Cited by 368 · see citing works

Losing balance: the origin and impact of aneuploidy in cancer

Holland, A. J., & Cleveland, D. W. (2012) · EMBO Reports · doi:10.1038/embor.2012.55 · Cited by 288 · see citing works

Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications

Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283 · see citing works

Genetic and epigenetic stability of human pluripotent stem cells

Lund, R., Närvä, E., & Lahesmaa, R. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3271 · Cited by 243 · see citing works

Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells

Ben‐David, U., Mayshar, Y., & Benvenisty, N. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.06.013 · Cited by 243 · see citing works

Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells

Ben-David, U., Arad, G., Weissbein, U., Mandefro, B., Maimon, A., Golan-lev, T., Narwani, K., Clark, A., Andrews, P., Benvenisty, N., et al. (2014) · Nature Communications · doi:10.1038/ncomms5825 · Cited by 189 · see citing works

Recurrent copy number variations in human induced pluripotent stem cells

Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213 · see citing works

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210 · see citing works

Elevated Coding Mutation Rate During the Reprogramming of Human Somatic Cells into Induced Pluripotent Stem Cells

Ji, J., Ng, S. H. S., Sharma, V., Neculai, D., Hussein, S. M. I., Sam, M., Trinh, Q. M., Church, G. M., McPherson, J. D., Nagy, A., et al. (2011) · Stem Cells · doi:10.1002/stem.1011 · Cited by 191 · see citing works

Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells

Valamehr, B. B., Robinson, M., Abujarour, R., Rezner, B., Vranceanu, F., Le, T. M., Medcalf, A., Lee, T. T., Fitch, M., Robbins, D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.014 · Cited by 178 · see citing works

A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells

Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C. E., Chu, P., Ryu, S., Deng, T., Ormanoglu, P., Tao, D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01126-2 · Cited by 173 · see citing works

iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types

Panopoulos, A. D., D’Antonio, M., Benaglio, P., Williams, R. M., Hashem, S. I., Schuldt, B. M., DeBoever, C., Arias, A. D., Garcia, M., Nelson, B., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.012 · Cited by 162 · see citing works

International regulatory landscape and integration of corrective genome editing into in vitro fertilization

Araki, M., & Ishii, T. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-108 · Cited by 150 · see citing works

Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells

Baker, D., Hirst, A. J., Gokhale, P. J., Juárez, M. A., Williams, S., Wheeler, M., Bean, K., Allison, T. F., Moore, H. D. M., Andrews, P. W., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.10.003 · Cited by 149 · see citing works

Genome editing of human pluripotent stem cells to generate human cellular disease models

Musunuru, K. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012054 · Cited by 151 · see citing works

Genome maintenance in pluripotent stem cells

Weissbein, U., Benvenisty, N., & Ben‐David, U. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201310135 · Cited by 143 · see citing works

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

Poetsch, M. S., Strano, A., & Guan, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac020 · Cited by 144 · see citing works

Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications

Peterson, S. E., & Loring, J. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.516419 · Cited by 142 · see citing works

White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies

Burns, A. J., Goldstein, A. M., Newgreen, D. F., Stamp, L. A., Schäfer, K., Metzger, M., Hotta, R., Young, H. M., Andrews, P. W., Thapar, N., et al. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.04.001 · Cited by 141 · see citing works

Pluripotent Stem Cell-based therapy for Parkinson’s disease: current status and future prospects

Sonntag, K. C., Song, B., Lee, N., Jung, J., Cha, Y.-G., Leblanc, P., Neff, C., Kong, S., Carter, B., Schweitzer, J. S., et al. (2018) · Progress in neurobiology · doi:10.1016/j.pneurobio.2018.04.005 · Cited by 127 · see citing works

Molecular Obstacles to Clinical Translation of iPSCs

Tapia, N., & Schöler, H. R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.017 · Cited by 141 · see citing works

Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair

Hartman, M. E., Dai, D., & Laflamme, M. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.004 · Cited by 140 · see citing works

Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells

Martins‐Taylor, K., & Xu, R. (2011) · Stem Cells · doi:10.1002/stem.705 · Cited by 136 · see citing works

Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation

D’Aiuto, L., Zhi, Y., Kumar Das, D., Wilcox, M. R., Johnson, J. W., McClain, L., MacDonald, M. L., Di Maio, R., Schurdak, M. E., Piazza, P., et al. (2014) · Organogenesis · doi:10.1080/15476278.2015.1011921 · Cited by 131 · see citing works

Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics

Krentz, N. A. J., & Gloyn, A. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0325-0 · Cited by 128 · see citing works

The mutational impact of culturing human pluripotent and adult stem cells

Kuijk, E., Jager, M., van der Roest, B., Locati, M. D., Van Hoeck, A., Korzelius, J., Janssen, R., Besselink, N., Boymans, S., van Boxtel, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16323-4 · Cited by 124 · see citing works

Whole-genome mutational burden analysis of three pluripotency induction methods

Bhutani, K., Nazor, K. L., Williams, R., Tran, H., Dai, H., Džakula, Ž., Cho, E. H., Pang, A. W. C., Rao, M., Cao, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10536 · Cited by 129 · see citing works

EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs

Ebert, A. D., Shelley, B., Hurley, A. M., Onorati, M., Castiglioni, V., Patitucci, T. N., Svendsen, S. P., Mattis, V. B., McGivern, J. V., Schwab, A. J., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.009 · Cited by 110 · see citing works

Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells

Rouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01147-3 · Cited by 105 · see citing works

Acquired genetic changes in human pluripotent stem cells: origins and consequences

Halliwell, J. A., Barbaric, I., & Andrews, P. W. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00292-z · Cited by 101 · see citing works

The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications

Ren, N., Atyah, M. M., Chen, W.-Y., & Zhou, C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1218-4 · Cited by 113 · see citing works

Primate cell fusion disentangles gene regulatory divergence in neurodevelopment

Agoglia, R. M., Sun, D., Birey, F., Yoon, S., Miura, Y., Sabatini, K., Pașca, S. P., & Fraser, H. B. (2021) · Nature · doi:10.1038/s41586-021-03343-3 · Cited by 102 · see citing works

Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.

Thatava, T., Kudva, Y., Edukulla, R., Squillace, K. A., Lamo, J. G. D., Khan, Y., Sakuma, T., Ohmine, S., Terzic, A., & Ikeda, Y. (2013) · Molecular Therapy · doi:10.1038/mt.2012.245 · Cited by 102 · see citing works

Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise

Duelen, R., & Sampaolesi, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.029 · Cited by 96 · see citing works

Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments

Kimberland, M. L., Hou, W., Alfonso-Pecchio, A. R., Wilson, S. P., Rao, Y., Zhang, S., & Lu, Q. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.08.007 · Cited by 96 · see citing works

Approaches for corneal endothelium regenerative medicine

Català, P., Thuret, G., Skottman, H., Mehta, J. S., Parekh, M., Dhubhghaill, S. N., Collin, R. W. J., Nuijts, R. M. M. A., Ferrari, S., LaPointe, V. L. S., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100987 · Cited by 94 · see citing works

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., et al. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01029-0 · Cited by 92 · see citing works

Temporal Analysis of Genome Alterations Induced by Single-Cell Passaging in Human Embryonic Stem Cells

Baï, Q., Ramirez, J., Becker, F., Pantesco, V., Lavabre‐Bertrand, T., Hovatta, O., Lemaı̂tre, J.-M., Pellestor, F., & Vos, J. D. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0292 · Cited by 88 · see citing works

Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation

Oikonomopoulos, A., Kitani, T., & Wu, J. C. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.026 · Cited by 89 · see citing works

Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases

Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89 · see citing works

Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach

D’Antonio, M., Benaglio, P., Jakubosky, D. A., Greenwald, W. W. Y., Matsui, H., Donovan, M. K. R., Li, H., Smith, E. N., D’Antonio‐Chronowska, A., & Frazer, K. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.091 · Cited by 87 · see citing works

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes

Kudva, Y. C., Ohmine, S., Greder, L. V., Dutton, J. R., Armstrong, A. S., Lamo, J. G. D., Khan, Y., Thatava, T., Hasegawa, M., Fusaki, N., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0044 · Cited by 87 · see citing works

Genetic and epigenetic instability in human pluripotent stem cells

Nguyen, H. T., Geens, M., & Spits, C. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms048 · Cited by 86 · see citing works

An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility

Madsen, A., Höppner, G., Krause, J., Hirt, M. N., Laufer, S. D., Schweizer, M., Tan, W. L. W., Mosqueira, D., Anene-Nzelu, C. G., Lim, I. Y., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044444 · Cited by 87 · see citing works

Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa

Tolar, J., McGrath, J., Xia, L., Riddle, M. J., Lees, C. J., Eide, C., Keene, D., Liu, L., Osborn, M. J., Lund, T. C., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.523 · Cited by 85 · see citing works

Mending a broken heart: current strategies and limitations of cell-based therapy

Liew, L. C., Ho, B. X., & Soh, B.-S. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01648-0 · Cited by 87 · see citing works

Blood Cell-Derived Induced Pluripotent Stem Cells Free of Reprogramming Factors Generated by Sendai Viral Vectors

Ye, L., Muench, M. O., Fusaki, N., Beyer, A. I., Wang, J., Qi, Z., Yu, J., & Kan, Y. W. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0006 · Cited by 85 · see citing works

Antioxidant Supplementation Reduces Genomic Aberrations in Human Induced Pluripotent Stem Cells

Ji, J., Sharma, V., Qi, S., Guarch, M. E., Zhao, P., Luo, Z., Fan, W., Wang, Y., Mbabaali, F., Neculai, D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.004 · Cited by 84 · see citing works

Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease

Doetschman, T., & Georgieva, T. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309727 · Cited by 83 · see citing works

A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types

Chen, C. X. ‐., Abdian, N., Maussion, G., Thomas, R. A., Demirova, I., Cai, E., Tabatabaei, M., Beitel, L. K., Karamchandani, J., Fon, E. A., et al. (2021) · Methods and Protocols · doi:10.3390/mps4030050 · Cited by 89 · see citing works

Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?

Assou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 74 · see citing works

High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells

D’Antonio, M., Woodruff, G., Nathanson, J. L., D’Antonio‐Chronowska, A., Arias, A. D., Matsui, H., Williams, R. M., Herrera, C. M., Reyna, S. M., Yeo, G. W.-M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.011 · Cited by 76 · see citing works

Corneal cell therapy: with iPSCs, it is no more a far-sight

Chakrabarty, K., Shetty, R., & Ghosh, A. (2018) · Stem cell research & therapeutics · doi:10.1186/s13287-018-1036-5 · Cited by 65 · see citing works

Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects

Lin, Y., Anderson, J. D., Rahnama, L. M. A., Gu, S. V., & Knowlton, A. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00075.2020 · Cited by 73 · see citing works

Systematic Review of Induced Pluripotent Stem Cell Technology as a Potential Clinical Therapy for Spinal Cord Injury

Kramer, A. S., Harvey, A. R., Plant, G. W., & Hodgetts, S. I. (2012) · Cell Transplantation · doi:10.3727/096368912x655208 · Cited by 73 · see citing works

The Potential for Immunogenicity of Autologous Induced Pluripotent Stem Cell-derived Therapies

Scheiner, Z. S., Talib, S., & Feigal, E. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.509588 · Cited by 72 · see citing works

Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality

Strässler, E. T., Aalto‐Setälä, K., Kiamehr, M., Landmesser, U., & Kränkel, N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00004 · Cited by 69 · see citing works

Induced Pluripotent Stem Cell Generation-Associated Point Mutations Arise during the Initial Stages of the Conversion of These Cells

Sugiura, M., Kasama, Y., Araki, R., Hoki, Y., Sunayama, M., Uda, M., Nakamura, M., Ando, S., & Abe, M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.006 · Cited by 68 · see citing works

Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process

Turinetto, V., Orlando, L., & Giachino, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091952 · Cited by 64 · see citing works

Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture

Shimamoto, A., Kagawa, H., Kazumasa, Z., Sera, Y., Kazuki, Y., Osaki, M., Oshimura, M., Ishigaki, Y., Hamasaki, K., Kodama, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112900 · Cited by 63 · see citing works

Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart Syndrome

Krane, M., Dreßen, M., Santamaria, G., My, I., Schneider, C. M., Dorn, T., Laue, S., Mastantuono, E., Berutti, R., Rawat, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056198 · Cited by 63 · see citing works

Successful Generation of Human Induced Pluripotent Stem Cell Lines from Blood Samples Held at Room Temperature for up to 48 hr

Agu, C. A., Soares, F. A. C., Alderton, A., Patel, M. J., Ansari, R. A., Patel, S. R., Forrest, S., Yang, F., Lineham, J., Vallier, L., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.012 · Cited by 63 · see citing works

Footprint-Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical-Grade Cell Source

Boreström, C., Simonsson, S., Enochson, L., Bigdeli, N., Brantsing, C., Ellerström, C., Hyllner, J., & Lindahl, A. H. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0138 · Cited by 63 · see citing works

Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee

Madrid, M., Lakshmipathy, U., Zhang, X., Bharti, K., Wall, D. M., Sato, Y., Muschler, G. F., Ting, A. E., Smith, N., Deguchi, S., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.022 · Cited by 67 · see citing works

Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective

Baï, Q., Desprat, R., Klein, B., Lemaı̂tre, J.-M., & Vos, J. D. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020003 · Cited by 62 · see citing works

Genomic stability in reprogramming

Ronen, D., & Benvenisty, N. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.09.003 · Cited by 61 · see citing works

Aneuploidy in pluripotent stem cells and implications for cancerous transformation

Na, J., Baker, D., Zhang, J., Andrews, P. W., & Barbaric, I. (2014) · Protein & Cell · doi:10.1007/s13238-014-0073-9 · Cited by 58 · see citing works

High Prevalence of Evolutionarily Conserved and Species-Specific Genomic Aberrations in Mouse Pluripotent Stem Cells

Ben‐David, U., & Benvenisty, N. (2012) · Stem Cells · doi:10.1002/stem.1057 · Cited by 60 · see citing works

Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics

Harding, J., & Mirochnitchenko, O. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.463737 · Cited by 60 · see citing works

Genomic Instability of iPSCs and Challenges in Their Clinical Applications

Yoshihara, M., Oguchi, A., & Murakawa, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_2 · Cited by 58 · see citing works

Nucleosides Rescue Replication-Mediated Genome Instability of Human Pluripotent Stem Cells

Halliwell, J. A., Frith, T. J. R., Laing, O., Price, C. J., Bower, O. J., Stavish, D., Gokhale, P. J., Hewitt, Z., El‐Khamisy, S. F., Barbaric, I., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.04.004 · Cited by 59 · see citing works

Assessing the Risks of Genotoxicity in the Therapeutic Development of Induced Pluripotent Stem Cells

Hong, S. G., Dunbar, C. E., & Winkler, T. (2012) · Molecular Therapy · doi:10.1038/mt.2012.255 · Cited by 58 · see citing works

Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine

Qiao, Y., Agboola, O. S., Hu, X., Wu, Y., & Lei, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10042-5 · Cited by 56 · see citing works

Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival

Zhang, J., Hirst, A. J., Duan, F., Qiu, H., Huang, R., Ji, Y., Bai, L., Zhang, F., Robinson, D. A., Jones, M., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.013 · Cited by 52 · see citing works

An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells

Guo, J., Ma, D., Huang, R., Ming, J., Ye, M., Kee, K., Xie, Z., & Na, J. (2017) · Protein & Cell · doi:10.1007/s13238-016-0360-8 · Cited by 55 · see citing works

Concise Review: Genomic Instability in Human Stem Cells: Current Status and Future Challenges

Oliveira, P. H., da Silva, C. L., & Cabral, J. M. S. (2014) · Stem Cells · doi:10.1002/stem.1796 · Cited by 53 · see citing works

Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders

Anderson, N. C., Chen, P.-F., Meganathan, K., Saber, W. A., Petersen, A. J., Bhattacharyya, A., Kroll, K. L., & Şahin, M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.025 · Cited by 47 · see citing works

Passage Number is a Major Contributor to Genomic Structural Variations in Mouse iPSCs

Liu, P., Kaplan, A., Yuan, B., Hanna, J. H., Lupski, J. R., & Reiner, O. (2014) · Stem Cells · doi:10.1002/stem.1779 · Cited by 47 · see citing works

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes

Christidi, E., Huang, H., Shafaattalab, S., Maillet, A., Lin, E. C., Huang, K., Laksman, Z., Davis, M. K., Tibbits, G. F., & Brunham, L. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65979-x · Cited by 45 · see citing works

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells

Kunitomi, A., Yuasa, S., Sugiyama, F., Saito, Y., Seki, T., Kusumoto, D., Kashimura, S., Takei, M., Tohyama, S., Hashimoto, H., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.015 · Cited by 46 · see citing works

Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells

Rohani, L., Johnson, A. A., Naghsh, P., Rancourt, D. E., Ulrich, H., & Holland, H. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0087 · Cited by 45 · see citing works

Single cell heterogeneity in human pluripotent stem cells

Yang, S., Cho, Y., & Jang, J. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.10.094 · Cited by 43 · see citing works

Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes

Lewandowski, J., Kolanowski, T. J., & Kurpisz, M. K. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2117 · Cited by 41 · see citing works

Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine

Botman, O., & Wyns, C. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00005 · Cited by 41 · see citing works

Developing Defined Culture Systems for Human Pluripotent Stem Cells

Valamehr, B. B., Tsutsui, H., Ho, C., & Wu, H. (2011) · Regenerative Medicine · doi:10.2217/rme.11.54 · Cited by 41 · see citing works

High-throughput karyotyping of human pluripotent stem cells

Lund, R., Nikula, T., Rahkonen, N., Närvä, E., Baker, D., Harrison, N., Andrews, P. W., Otonkoski, T., & Lahesmaa, R. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.06.008 · Cited by 40 · see citing works

Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products

Nezhad, M. S., Abdollahpour‐Alitappeh, M., Rezaei, B., Yazdanifar, M., & Seifalian, A. M. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03067-z · Cited by 41 · see citing works

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes

Pellegrini, S., Zamarian, V., & Sordi, V. (2022) · Transplant International · doi:10.3389/ti.2022.10575 · Cited by 38 · see citing works

The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges

Khazaei, M., Siddiqui, A. M., & Fehlings, M. G. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm4010037 · Cited by 38 · see citing works

Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming

Shimamoto, A., Yokote, K., & Tahara, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00010 · Cited by 38 · see citing works

DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing

Šimara, P., Tesařová, L., Řeháková, D., Matula, P., Stejskal, S., Hampl, A., & Koutná, I. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0522-5 · Cited by 38 · see citing works

Achilles’ heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture

Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 36 · see citing works

Turning regenerative technologies into treatment to repair myocardial injuries

Carotenuto, F., Teodori, L., Maccari, A. M., Delbono, L., Orlando, G., & Nardo, P. D. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14630 · Cited by 36 · see citing works

Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications

Steichen, C., Hannoun, Z., Luce, E., Hauet, T., & Dubart‐Kupperschmitt, A. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i10.729 · Cited by 36 · see citing works

Generation of human induced pluripotent stem cells using non-synthetic mRNA

Rohani, L., Fabian, C., Holland, H., Naaldijk, Y., Dressel, R., Loeffler‐Wirth, H., Binder, H., Arnold, A., & Stolzing, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.008 · Cited by 36 · see citing works

Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Biendarra‐Tiegs, S. M., Secreto, F. J., & Nelson, T. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_350 · Cited by 35 · see citing works

Culture under low physiological oxygen conditions improves the stemness and quality of induced pluripotent stem cells

Guo, C., Kawakatsu, M., Idemitsu, M., Urata, Y., Goto, S., Ono, Y., Hamano, K., & Li, T. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24389 · Cited by 35 · see citing works

Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases

Hibaoui, Y., & Féki, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00267 · Cited by 35 · see citing works

Recurrent copy number variations in human induced pluripotent stem cells

Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213 · see citing works

Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells

Rouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01147-3 · Cited by 105 · see citing works

Chromosome correction through reprogramming

Burgess, D. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3680

Chromosomal Instability and Karyotype Correction in Human Induced Pluripotent Stem Cells

Tv, N., Кашеварова, А. А., & Лебедев, И. Н. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419100090 · Cited by 5 · see citing works

Large-scale genomic analysis of human iPSCs identifies recurrent somatic driver mutations

(2022) · Nature Genetics · doi:10.1038/s41588-022-01169-x · Cited by 2 · see citing works